XML 106 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2011
Income Taxes [Abstract]  
Summary Of Components Of Income Before Income Taxes And The Provision For Income Taxes
     Year ended December 31,  
(in thousands)    2011     2010     2009  

Income (loss) before income taxes:

      

Domestic

   $ 252,381      $ 210,819      $ 37,020   

Foreign

     (44,374     (9,933     (7,068
  

 

 

   

 

 

   

 

 

 

Income before income taxes

   $ 208,007      $ 200,886      $ 29,952   
  

 

 

   

 

 

   

 

 

 

Income tax expense (benefit):

      

Current:

      

Federal

   $ 79,850      $ 45,727      $ 7,614   

State and local

     6,601        9,684        4,018   

Foreign

     337        (33     16   
  

 

 

   

 

 

   

 

 

 

Subtotal

     86,788        55,378        11,648   

Deferred:

      

Federal

     1,318        26,926        21,588   

State and local

     (8,136     (4,198     10,684   

Foreign

     (12,622     (2,828     (2,891
  

 

 

   

 

 

   

 

 

 

Subtotal

     (19,440              
  

 

 

   

 

 

   

 

 

 

Income tax expense

   $ 67,348      $ 75,278      $ 41,029   
  

 

 

   

 

 

   

 

 

 

Effective income tax rate

     32.4     37.5     137.0
Schedule Of Reconciliation Of Federal Statutory Income Tax Rate To The Effective Income Tax Rate
     Year ended December 31,  
(% of pre-tax income)    2011     2010     2009  

U.S. federal statutory income tax rate

     35.0     35.0     35.0

State and local income tax, net of federal tax benefit

     1.7        1.8        44.3   

Share-based compensation

     0.3        0.6        5.0   

Orphan drug credit

     (0.2     (0.2     (20.5

Change in valuation allowance

     (2.2     0.1        (1.6

Impairments

     —          —          75.8   

Manufacturing deduction

     (4.1     —          —     

Foreign rate differential

     1.0        —          —     

Other

     0.9        0.2        (1.0
  

 

 

   

 

 

   

 

 

 

Effective income tax rate

     32.4     37.5     137.0
  

 

 

   

 

 

   

 

 

 
Summary Of Components Of Deferred Income Tax Assets And Liabilities
     December 31,  
(in thousands)    2011     2010  

Deferred tax assets:

    

Net operating loss carryforwards

   $ 17,893      $ 13,421   

Capitalized research and development costs

     6,503        6,419   

Orphan drug credit carryforward

     —          1,482   

Research and development credit carryforward

     —          3,449   

Non-deductible reserves

     6,118        5,385   

Depreciation

     273        670   

Intangible asset amortization

     11,179        6,965   

Equity compensation

     10,783        9,770   

Other

     1,267        1,316   
  

 

 

   

 

 

 

Subtotal

     54,016        48,877   

Valuation allowance

     (4,876     (6,238
  

 

 

   

 

 

 

Deferred tax assets

     49,140        42,639   

Deferred tax liabilities:

    

Intangible asset amortization

     198,334        192,963   

Convertible note

     6,335        6,584   

Prepaid expenses

     1,388        1,207   
  

 

 

   

 

 

 

Deferred tax liabilities

     206,057        200,754   
  

 

 

   

 

 

 

Net deferred tax assets (liability)

   $ (156,917   $ (158,115
  

 

 

   

 

 

 
Schedule Of Deferred Tax Assets And Liabilities Classification
     December 31,  
(in thousands)    2011     2010  

Current assets

   $ 10,055      $ 13,744   

Non-current assets

     11,786        4,252   

Current liabilities

     (52     —     

Non-current liabilities

     (178,706     (176,111
  

 

 

   

 

 

 

Net deferred tax liability

   $ (156,917   $ (158,115
  

 

 

   

 

 

 
Summary Of Changes In Valuation Allowance
     Year ended December 31,  
(in thousands)    2011     2010      2009  

Valuation allowance at beginning of year

   $ 6,238      $ 5,949       $ 6,436   

Tax expense (benefit)

     (4,662     289         (487

Acquisitions

     3,435        —           —     

Foreign exchange

     (135     —           —     
  

 

 

   

 

 

    

 

 

 

Valuation allowance at end of year

   $ 4,876      $ 6,238       $ 5,949   
  

 

 

   

 

 

    

 

 

 
Summary Of Carryforwards Of Net Operating Losses And Tax Credits